Showing results (281-290 of 312) with videos related to
Sort By:
Pageof 32
International Journal of Radiation Oncology, Biology, Physics|February 13, 2016
Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerAndrew Warner, Max Dahele, Bo Hu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2024
Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location: Guidelines from the American Radium SocietyHenry S Park, Andreas Rimner, Arya Amini, et al.Canadian Journal of Kidney Health and Disease|November 25, 2021
A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research ProtocolAnshika Jain, Ryan Huang, Jasmine Lee, et al.International Journal of Radiation Oncology, Biology, Physics|August 31, 2019
Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized TrialRobert Olson, Suresh Senan, Stephen Harrow, et al.Practical Radiation Oncology|June 10, 2017
Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based GuidelineGregory M M Videtic, Jessica Donington, Meredith Giuliani, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2024
Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized TrialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.The Lancet. Oncology|August 17, 2019
Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trialAnthony C Nichols, Julie Theurer, Eitan Prisman, et al.The Journal of Urology|May 10, 2022
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future DirectionsJames A Eastham, Gregory B Auffenberg, Daniel A Barocas, et al.The Journal of Urology|May 10, 2022
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based ManagementJames A Eastham, Gregory B Auffenberg, Daniel A Barocas, et al.Cureus|January 17, 2020
A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain OligometastasesGeorge Rodrigues, Slav Yartsev, David Roberge, et al.Pageof 32